Prognosis after aortic root replacement with cryopreserved allografts in adults

Annals of Thoracic Surgery

Volumn 75, Issue 5, 2003, Pages 1482-1489

  Takkenberg, Johanna J M ^a   Eijkemans, Marinus J C ^b   Van Herwerden, Lex A ^b   Steyerberg, Ewout W ^b   Lane, Mary M ^b   Elkins, Ronald C ^b   Habbema, J Dik F ^b   Bogers, Ad J J C ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLOGRAFT; AORTA PROSTHESIS; AORTA RECONSTRUCTION; AORTA ROOT; AORTA VALVE DISEASE; ARTICLE; CLINICAL TRIAL; CRYOPRESERVATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; REOPERATION; RISK ASSESSMENT; ADOLESCENT; AGE; AORTA VALVE; DISEASE FREE SURVIVAL; LIFE EXPECTANCY; MIDDLE AGED; POSTOPERATIVE COMPLICATION; PROPORTIONAL HAZARDS MODEL; PROSTHESIS FAILURE; RISK FACTOR; STATISTICAL MODEL; TRANSPLANTATION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AORTIC VALVE; CRYOPRESERVATION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LIFE EXPECTANCY; MALE; MIDDLE AGED; MODELS, STATISTICAL; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSTHESIS FAILURE; REOPERATION; RISK FACTORS;

EID: 0037408111     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(02)04722-7     Document Type: Article

References (31)

1. Lund O, Chandrasekaran V, Grocott-Mason R, et al. Primary aortic valve replacement with allografts over twenty-five years: valve-related and procedure-related determinants of outcome. J Thorac Cardiovasc Surg 1999;117:77-90.
2. O'Brien MF, Finney RS, Stafford EG, et al. Root replacement for all allograft aortic valves: preferred technique or too radical? Ann Thorac Surg 1995;60:S87-91.
3. Knott-Craig CJ, Elkins RC, Santangelo KL, McCue C, Lane MM. Aortic valve replacement: comparison of late survival between autografts and homografts. Ann Thorac Surg 2000;69:1327-32.
4. O'Brien MF, Stafford EG, Gardner MA, et al. Allograft aortic valve replacement: long-term follow-up. Ann Thorac Surg 1995;60:S65-70.
5. Blettner M, Sauerbrei W, Schlehofer B, Scheuchenpflug T, Friedenreich C. Traditional reviews, meta-analyses and pooled analyses in epidemiology. Int J Epidemiol 1999;28:1-9.
6. Edmunds LH Jr, Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. The American Association for Thoracic Surgery, Ad Hoc Liason Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity. Ann Thorac Surg 1996;62:932-5.
7. Fleiss JL. The statistical basis of meta-analysis. Stat Methods Med Res 1993;2:121-45.
8. Law AM, Kelton WD. Simulation modeling and analysis, 2nd ed. New York: McGraw-Hill, 1991.
9. Grunkemeier GL, Chandler JG, Miller DC, Jamieson WR, Starr A. Utilization of manufacturers' implant card data to estimate heart valve failure. J Heart Valve Dis 1993;2:493-503.
10. Thoman DR, Bain LJ, Antle CE. Inferences on the parameters of the Weibull distribution. Technometrics 1969;11:445-60.
11. Grunkemeier GL, Li HH, Naftel DC, Starr A, Rahimtoola SH. Long-term performance of heart valve prostheses. Curr Probl Cardiol 2000;25:73-154.
12. Steyerberg EW, Eijkemans MJ, Van Houwelingen JC, Lee KL, Habbema JD. Prognostic models based on literature and individual patient data in logistic regression analysis. Stat Med 2000;19:141-60.
13. Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 1987;9:1-30.
14. Blackstone EH. The choice of a prosthetic heart valve: how shall patient-specific recommendations be made? J Heart Valve Dis 1998;7:1-3.
15. Kvidal P, Bergstrom R, Horte LG, Stahle E. Observed and relative survival after aortic valve replacement. J Am Coll Cardiol 2000;35:747-56.
16. Steyerberg EW, Kallewaard M, van der Graaf Y, van Herwerden LA, Habbema JD. Decision analyses for prophylactic replacement of the Bjork-Shiley convexo-concave heart valve: an evaluation of assumptions and estimates. Med Decis Making 2000;20:20-32.
17. van der Meer FJ, Rosendaal FR, Vandenbroucke JP, Briet E. Assessment of a bleeding risk index in two cohorts of patients treated with oral anticoagulants. Thromb Haemost 1996;76:12-6.
18. Takkenberg JJM, Puvimanasinghe JPA, van Herwerden LA, et al. Prognosis after aortic valve replacement with SJM bileaflet prostheses: impact on outcome of varying thromboembolic hazard. Eur Heart J 2001;3(Suppl Q):Q27-32.
19. Puvimanasinghe JP, Steyerberg EW, Takkenberg JJ, et al. Prognosis after aortic valve replacement with a bioprosthesis: predictions based on meta-analysis and microsimulation. Circulation 2001;103:1535-41.
20. Takkenberg JJ, Eijkemans MJ, van Herwerden LA, et al. Estimated event-free life expectancy after autograft aortic root replacement in adults. Ann Thorac Surg 2001;7:S344-8.
21. Dossche KM, Brutel de la Riviere A, Morshuis WJ, Schepens MA, Defauw JJ, Ernst SM. Cryopreserved aortic allografts for aortic root reconstruction: a single institution's experience. Ann Thorac Surg 1999;67:1617-22.
22. O'Brien MF, Harrocks S, Stafford EG, et al. The homograft aortic valve: a 29-year, 99.3% follow up of 1,022 valve replacements. J Heart Valve Dis 2001;10:334-44.
23. Breslow NE, Day NE. Statistical methods in cancer research. The design and analysis of cohort studies. Oxford: Oxford University Press, 1987.
24. Prager RL, Fischer CR, Kong B, et al. The aortic homograft: evolution of indications, techniques, and results in 107 patients. Ann Thorac Surg 1997;64:659-63.
25. Barratt-Boyes BG, Roche AH, Subramanyan R, Pemberton JR, Whitlock RM. Long-term follow-up of patients with the antibiotic-sterilized aortic homograft valve inserted free-hand in the aortic position. Circulation 1987;75:768-77.
26. Oei FB, Welters MJ, Knoop CJ, et al. Circulating donor-specific cytotoxic T lymphocytes with high avidity for donor human leukocyte antigens in pediatric and adult cardiac allograft valved conduit recipients. Eur J Cardiothorac Surg 2000;18:466-72.
27. Schoen FJ, Mitchell RN, Jonas RA. Pathological considerations in cryopreserved allograft heart valves. J Heart Valve Dis 1995;4(Suppl 1):S72-5.
28. Grunkemeier GL, Bodnar E. Comparison of structural valve failure among different 'models' of homograft valves. J Heart Valve Dis 1994;3:556-60.
29. Grunkemeier GL, Jamieson WR, Miller DC, Starr A. Actuarial versus actual risk of porcine structural valve deterioration. J Thorac Cardiovasc Surg 1994;108:709-18.
30. Verheul HA, van den Brink RB, Bouma BJ, et al. Analysis of risk factors for excess mortality after aortic valve replacement. J Am Coll Cardiol 1995;26:1280-6.
31. Birkmeyer NJO, Birkmeyer JD, Tosteson ANA, Grunkemeier GL, Marrin CA, O'Connor GT. Prosthetic valve type for patients undergoing aortic valve replacement: a decision analysis. Ann Thorac Surg 2000;70:1946-52.